Exact Mass: 273.10865620000004
Exact Mass Matches: 273.10865620000004
Found 500 metabolites which its exact mass value is equals to given mass value 273.10865620000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
beta-Erythroidine
C16H19NO3 (273.13648639999997)
An organic heterotetracyclic indole alkaloid isolated from the seeds and other parts of Erythrina species. It differs from the alpha isomer in having the double bond of the dihydropyranone ring located beta,gamma- to the lactone carbonyl group instead of alpha,beta-.
Tolcapone
Tolcapone is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinsons disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. Tolcapone is associated with a risk of hepatotoxicity. [Wikipedia] D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene
Norgalantamine
C16H19NO3 (273.13648639999997)
N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].
Sanguinine
C16H19NO3 (273.13648639999997)
Sanguinine is a benzazepine. Sanguinine is a natural product found in Lycoris sanguinea, Lycoris squamigera, and other organisms with data available. O-Desmethyl Galanthamine (Sanguinine) is galanthamine-type alkaloid. O-Desmethyl Galanthamine is an acetylcholinesterase (AChE) inhibitor, with an IC50 1.83 μM[1].
1,6-Dihydro-1-(3-methoxyphenethyl)-6-oxonicotinic acid
Ketamine hydrochloride
C13H17Cl2NO (273.06871320000005)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
4-O-Methylnorbelladine
C16H19NO3 (273.13648639999997)
A phenethylamine alkaloid that is norbelladine in which the phenolic hydrogen at position 4 has been replaced by a methyl group.
(E,E)-Piperlonguminine
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine is a member of benzodioxoles. Piperlonguminine is a natural product found in Piper amalago, Piper retrofractum, and other organisms with data available. (E,E)-Piperlonguminine is found in herbs and spices. (E,E)-Piperlonguminine is an alkaloid from Piper longum (long pepper) and other Piper specie Alkaloid from Piper longum (long pepper) and other Piper subspecies (E,E)-Piperlonguminine is found in herbs and spices. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].
Modafinil
C15H15NO2S (273.08234500000003)
Modafinil is a stimulant drug marketed as a wakefulness promoting agent and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. The exact mechanism of action is unclear, although in vitro studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular dopamine. Modafinil activates glutamatergic circuits while inhibiting GABA. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2E)-Piperamide-C5:1
C16H19NO3 (273.13648639999997)
(2E)-Piperamide-C5:1 is found in herbs and spices. (2E)-Piperamide-C5:1 is a constituent of pepper fruits (Piper nigrum, Piperaceae). Constituent of pepper fruits (Piper nigrum, Piperaceae). (2E)-Piperamide-C5:1 is found in herbs and spices and pepper (spice).
L-Thyronine
Thyronine (T0) is a de-iodinated form of thyroxine. Thyronine are a group of metabolites derived from thyroxine and triiodothyronine via the peripheral enzymatic removal of iodines from the thyroxine nucleus. Thyronine is the thyroxine nucleus devoid of its four iodine atoms. Thyronine (T0) has been identified in human urine. In 22 normal individuals urinary thyronine concentrations were found to range between 8-25 nmol‚ÅÑ24h (PMID: 479355). Thyronine is thought to be a byproduct of thyroxine metabolism and arises through the action of thyroxine deiodinases. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Glutaconylcarnitine
Glutaconylcarnitine is an acylcarnitine. More specifically, it is an glutaconic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Glutaconylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine glutaconylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
N-Despropyl-rotigotine
N-Despropyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)
N-Acetyl desmethyl frovatriptan
C15H19N3O2 (273.14771939999997)
N-Acetyl desmethyl frovatriptan is a metabolite of frovatriptan. Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. (Wikipedia)
(3E)-Glutaconylcarnitin
(3E)-Glutaconylcarnitin is an acylcarnitine. More specifically, it is an (3E)-pent-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Glutaconylcarnitin is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Glutaconylcarnitin is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2,5-Dioxopyrrolidin-1-yl) 5-(2-hydroxyethoxy)-4-oxopentanoate
C11H15NO7 (273.08484799999997)
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, methyl ester
Hhcfu
C11H16FN3O4 (273.11247879999996)
Desmethylcyproheptadine
N-Desmethyl zolmitriptan
C15H19N3O2 (273.14771939999997)
N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-toluidine
Nebicapone
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C471 - Enzyme Inhibitor
Norgalanthamine
C16H19NO3 (273.13648639999997)
Pomalidomide
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors
Prodolic acid
C16H19NO3 (273.13648639999997)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
indole-3-acetyl-valine
Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupua√ßu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products. Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupuaçu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products.
4,8-dimethoxy-3-(3-methylbut-2-enyl)-1H-quinolin-2-one
C16H19NO3 (273.13648639999997)
8-(gamma,gamma-dimethylallyloxy)-4-methoxy-N-methyl-2-quinolone
C16H19NO3 (273.13648639999997)
metazachlor OXA
A monocarboxylic acid that is oxoacetic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 706 CONFIDENCE standard compound; INTERNAL_ID 2062
10-Methoxy-3,12-didehydrogalanthan-1,9-diol #
C16H19NO3 (273.13648639999997)
8-O-demethylmaritidine|9-O-Demethylmaritidine
C16H19NO3 (273.13648639999997)
(3R),5-dihydroxy-(4S)-methyl-3,4-dihydro-2,9,10-(2H)-1-azaanthracenetrione|laoticuzanone A
4-O-Demethylmesembrenon|4-O-Demethylmesembrenone
C16H19NO3 (273.13648639999997)
1,2-O-Isopropylidene,N,5-Di-Ac-alpha-D-Furanose-3-Amino-3-deoxyribose
(2E,4E,6E)-7-(2-thienyl)-2,4-6-heptatrienoic acid piperidide|1-[(2E,4E,6E)-1-oxo-7-(2-thienyl)heptatrienyl]piperidine|1-[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]piperidine|7-(thiophene)-2E,4E,6E-heptatrienoic acid piperidide|N-piperidineotanthusic acid amide|Otanthus acid piperidide|Otanthus Maritima amide|Otanthussaeure-piperidid
3-(1-hydroxyethyl)-6-(indol-3-ylmethyl)-2,5-diketopiperazine|cyclo(L-Trp-L-Ser-)|cyclo(L-tryptophanyl-L-seryl)|cyclo-L-Trp-L-Ser
(-)-2-Isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]chinolin-4-on|(-)-2-isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]quinolin-4-one|2.3.4.5-tetrahydro-2-isopropyl-6-methoxy-5-methyl-4-oxo-furano<3.2-c>chinolin
C16H19NO3 (273.13648639999997)
(8aS,9R,11R,12aS)-6,7,8,8a,9,10,11,12-octahydro-8a-hydroxy-11-methyl-1,9-ethanobenzo[i]quinolizin-13,14-dione|huperzine F
C16H19NO3 (273.13648639999997)
(1S,1R)-1-hydroxy-4-(2,6-dideoxy-beta-D-xylo-hexapyranosyloxy)-2-cyclopentene-1-carboxamide
Norgalantamine
Norgalanthamine is a benzazepine. Norgalanthamine is a natural product found in Lycoris squamigera, Hymenocallis rotata, and other organisms with data available. N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].
Pomalidomide
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors
Tolcapone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4727; ORIGINAL_PRECURSOR_SCAN_NO 4722 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4810; ORIGINAL_PRECURSOR_SCAN_NO 4806 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4841; ORIGINAL_PRECURSOR_SCAN_NO 4839 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4812; ORIGINAL_PRECURSOR_SCAN_NO 4809 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4900; ORIGINAL_PRECURSOR_SCAN_NO 4896 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4752; ORIGINAL_PRECURSOR_SCAN_NO 4748
thyronine
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5-Hydroxymethylcytidine
5-(Hydroxymethyl)cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
provigil
C15H15NO2S (273.08234500000003)
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(E,E)-Piperlonguminine; AIF; CE0; CorrDec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE10; CorrDec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE30; CorrDec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE0; MS2Dec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE10; MS2Dec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE30; MS2Dec
C16H19NO3 (273.13648639999997)
piperlonguminine
C16H19NO3 (273.13648639999997)
Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].
Piperamide-C5:1 (2E)
C16H19NO3 (273.13648639999997)
5-TRIFLUOROMETHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER
ethyl 5-tert-butyl-3-formyl-1H-indole-2-carboxylate
C16H19NO3 (273.13648639999997)
3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole
5-ALLYLOXY-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER
C16H19NO3 (273.13648639999997)
4-[3-(1,3-BENZODIOXOL-5-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDINE
Tricyclo[3.3.1.13,7]decane, 1-(4-nitrophenyl)
C16H19NO3 (273.13648639999997)
5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-(TRIFLUOROMETHYL)PYRIDINE
methyl 5,5,5-trifluoro-4-(4-methylphenyl)iminopentanoate
methyl 5,5,5-trifluoro-4-(2-methylphenyl)iminopentanoate
methyl 5,5,5-trifluoro-4-(3-methylphenyl)iminopentanoate
7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid
4-ALLYL-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL
BENZYL 4-OXO-2-PROPYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE
C16H19NO3 (273.13648639999997)
BENZYL 2-ISOPROPYL-4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE
C16H19NO3 (273.13648639999997)
2-(4-methylphenyl)sulfonyl-1,3-dihydroisoindole
C15H15NO2S (273.08234500000003)
(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine
3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid,hydrochloride
(Meso-1R,5S,6R)-Ethyl 3-Benzyl-2,4-Dioxo-3-Azabicyclo[3.1.0]Hexane-6-Carboxylate
(S)-MORPHOLINE-3,4-DICARBOXYLICACID4-TERT-BUTYLESTER
5-Trifluoromethylpyridine-3-boronic acid pinacol ester
1-(3-FLUOROBENZYL)-4-PIPERIDINECARBOXYLICACIDHYDROCHLORIDE
1-Benzyl-3-trifluoromethyl-pyrrolidine-3-carboxylic acid
4-(1-Piperazinyl)-1H-indole dihydrochloride
C12H17Cl2N3 (273.07994620000005)
4-(2-cyclohexylethylamino)-2-nitrobenzonitrile
C15H19N3O2 (273.14771939999997)
6-(ALLYLOXY)-1-ETHYL-4-OXO-1,4-DIHYDROQUINOLINE-2-CARBOXYLIC ACID
1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone
C15H19N3O2 (273.14771939999997)
2-CYCLOHEXYL-1,3-DIOXO-2,3-DIHYDRO-1 H-ISOINDOLE-5-CARBOXYLIC ACID
5-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
trichloro(N,N-dimethyloctylamine)boron
C10H23BCl3N (273.0989038000001)
2-Trifluoromethylpyridine-4-boronic acid pinacol ester
Naphazoline nitrate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naphazoline (Naphthazoline) nitrate is an α-adrenergic receptor agonist. Naphazoline nitrate reduces vascular hyperpermeability and promotes vasoconstriction. Naphazoline nitrate reduces the levels of inflammatory factors (TNF-α, IL-1β and IL-6), cytokines (IFN-γ and IL-4), IgE, GMCSF, and NGF。Naphazoline nitrate can be used for non-bacterial conjunctivitis research[1][2].
4-(Aminomethyl)-4-(3,4-dichlorophenyl)cyclohexanol
C13H17Cl2NO (273.06871320000005)
(1R,4R)-1-(AMINOMETHYL)-4-(4-FLUOROBENZYL)CYCLOHEXANOL HYDROCHLORIDE
C14H21ClFNO (273.12956180000003)
esketamine hydrochloride
C13H17Cl2NO (273.06871320000005)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
METHYL3-{[2-(DIAMINOMETHYLENEAMINO)THIAZOL-4-YL]METHYLTHIO}PROPANIMIDATE
5-Nitro-2-(3-piperidinylmethoxy)pyridinehydrochloride
C11H16ClN3O3 (273.08801359999995)
(R)-2-(diphenylmethyl)pyrrolidine hydrochloride
C17H20ClN (273.12841900000006)
4-(aminomethyl)-4-(3,4-dichlorophenyl)cyclohexan-1-ol
C13H17Cl2NO (273.06871320000005)
Methoxypolyethylene glycol succinate N-hydroxysuccinimide
C11H15NO7 (273.08484799999997)
2-(2-PYRIDIN-2-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE
2-(2-PYRIDIN-3-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE
2-(2-PYRIDIN-4-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE
2-(4-methoxy-N-methylsulfonylanilino)propanoic acid
2-(tert-Butyl)-3-hydroxy-4-(trifluoromethyl)isoindolin-1-one
2-(tert-Butyl)-3-hydroxy-5-(trifluoromethyl)isoindolin-1-one
1-BOC-4-(METHOXYCARBONYL)PYRROLIDINE-3-CARBOXYLIC ACID
3-(4-Fluorophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazole-1-carboxamide
3-(2-PHENYL-IMIDAZOL-1-YL)-PROPYLAMINE DIHYDROCHLORIDE
C12H17Cl2N3 (273.07994620000005)
6-PHENETHYLCARBAMOYL-CYCLOHEX-3-ENECARBOXYLIC ACID
C16H19NO3 (273.13648639999997)
5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid,hydrochloride
(S)-(-)- 6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3- CARBOXYLIC ACID HYDROCHLORIDE
ETHYL 2-ISOPROPOXY-4-METHOXYBENZIMIDATE HYDROCHLORIDE
4,4-Diphenylpiperidine hydrochloride
C17H20ClN (273.12841900000006)
tert-Butyl 4-methoxynaphthalen-2-ylcarbamate
C16H19NO3 (273.13648639999997)
6-nitro-4-oxo-7-propan-2-yloxy-1H-quinoline-3-carbonitrile
1-Methyl-1-propylpyrrolidinium hexafluorophosphate
1-tert-butoxycarbonylisoquinoline-3-carboxylic acid
1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethanamine
1-Piperidinecarboxylic acid, 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-, ethyl ester
C15H19N3O2 (273.14771939999997)
3-(3-CYCLOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE
C16H19NO3 (273.13648639999997)
1-(4-Trifluoromethylphenyl)piperidine-4-carboxylic acid
1-(4-FLUORO-BENZYL)-PIPERIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
2-Pyridin-4-yl-benzo[h]chromen-4-one
D004791 - Enzyme Inhibitors > D001571 - Benzoflavones
Ethyl morpholine-2-carboxylate 2,2,2-trifluoroacetate
2-Amino-8-benzyl-2,8-diazaspiro[4.5]decane-1,3-dione
C15H19N3O2 (273.14771939999997)
ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enoic acid
tert-butyl N-[2-(2,4-difluorophenyl)-2-hydroxyethyl]carbamate
(3-(N-isopropylsulfamoyl)-4-Methoxyphenyl)boronic acid
C10H16BNO5S (273.08421960000004)
5-propan-2-yl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
(-)-n,n-dimethylephedrinium bromide
C12H20BrNO (273.07281700000004)
Methyl 2-amino-5-(3-chloropropoxy)-4-methoxybenzoate
2-(tert-Butyl)-3-hydroxy-6-(trifluoromethyl)isoindolin-1-one
3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)aniline
(R)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine
N-Cbz-9-azabicyclo[3.3.1]nonan-3-one
C16H19NO3 (273.13648639999997)
2-(2-Chlorophenyl)-1-[4-(dimethylamino)phenyl]ethanone
3-Amino-6-(4-methylphenyl)pyrazinecarboxylicacidethylester-4-oxide
Oxaflozane
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants
2-(Benzofuran-2-yl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione,2-Benzofuranboronic acid MIDA ester
2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-1,3,4-oxadiazole
armodafinil
C15H15NO2S (273.08234500000003)
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-indazole
1-Benzyl-4-trifluoromethyl-pyrrolidine-3-carboxylic acid
Pyrrole-2,4-dicarboxylic acid, 3,5-dimethyl-, 4-benzyl ester (7CI)
2-(TERT-BUTYL)-7-HYDRAZINO-5-(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDINE
C11H14F3N5 (273.12012400000003)
5-diethylaminomethyl-2-phenyl-furan-3-carboxylic acid
C16H19NO3 (273.13648639999997)
(R)-(+)-alpha-[(3-Methoxy-1-methyl-3-oxo-1-propenyl)amino]-1,4-cyclohexadiene-1-acetic acid sodium salt
4-METHYL-N-(4-METHYL-BENZYLIDENE)BENZENESULFONAMIDE
C15H15NO2S (273.08234500000003)
(3-(BENZYLCARBAMOYL)-4-FLUOROPHENYL)BORONIC ACID
C14H13BFNO3 (273.09724700000004)
(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone
6-(trifluoromethyl)pyridine-2-boronic acid pinacol ester
1,6-Dihydro-4-hydroxy-2-methyl-6-oxo-1-phenyl-3-pyridinecarboxylic acid ethyl ester
[2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER
2-(tert-Butylamino)-3,4-chloropropiophenone hydrochloride
C13H17Cl2NO (273.06871320000005)
Mavacamten
C15H19N3O2 (273.14771939999997)
C - Cardiovascular system > C01 - Cardiac therapy
2-propenoic acid, 3-[2-[(3,5-dimethyl-4-isoxazolyl)methoxy
(S)-6,7 DIMETHOXY 1,2,3,4 TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLOIC ACID HYDROCHLORIDE
4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexanol
[1-(2,6-Dichloro-benzyl)-piperidin-2-yl]-methanol
C13H17Cl2NO (273.06871320000005)
(2-{[1-Ethyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]methoxy}ethyl)amine hydrochloride
1-(4-METHOXY-2-NITROPHENYL)PIPERAZINE HYDROCHLORIDE
C11H16ClN3O3 (273.08801359999995)
Viloxazine hydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
1-(1-methylpyrazol-4-yl)sulfonylpiperidine-4-carboxylic acid
3-(1,2,3,4-TETRAHYDROQUINOLIN-2-YL)-2-(TRIFLUOROMETHYL) PROPIONIC ACID
D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-(2-PROPENYL) ESTER
4-[2-(Methyl-2-pyridinyl)amino]ethoxyl nitrobenzene
3-(4-Benzyloxyphenoxy)-2-hydroxypropanamine
C16H19NO3 (273.13648639999997)
1-[(tert-butoxy)carbonyl]-3-(ethoxycarbonyl)azetidine-3-carboxylic acid
N-(2-aminopyrimidin-5-yl)-2-methyl-5-nitrobenzamide
1-[3-amino-5-[4-(tert-butyl)phenyl]-2-thienyl]ethan-1-one
(5-(Benzylcarbamoyl)-2-fluorophenyl)boronic acid
C14H13BFNO3 (273.09724700000004)
(4-(Benzylcarbamoyl)-3-fluorophenyl)boronic acid
C14H13BFNO3 (273.09724700000004)
(3-(Benzylcarbamoyl)-5-fluorophenyl)boronic acid
C14H13BFNO3 (273.09724700000004)
2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethanamine
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline
2-oxo-7-aza-spiro[3.5]nonane-7-carboxylic acid benzyl ester
C16H19NO3 (273.13648639999997)
4,7-Methano-1H-(1,2)diazeto(3,4-f)benzotriazole, 1-(4-chlorophenyl)-3a,4,4a,6a,7,7a-hexahydro-
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, methyl ester
D000970 - Antineoplastic Agents > D020032 - Tyrphostins
4-(5-Methoxy-1,2-dimethyl-1h-indol-3-yl)thiazol-2-ylamine
2-methyl-N-[(E)-(2-nitrophenyl)methylideneamino]furan-3-carboxamide
BENZOIC ACID, p-((2,4,6-TRIAMINO-5-PYRIMIDINYL)AZO)-
C11H11N7O2 (273.09741859999997)
(E)-1-(4-methylphenyl)-3-quinolin-6-ylprop-2-en-1-one
2-[(4-Chloro-2-methylphenoxy)methyl]imidazo[1,2-a]pyrimidine
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one
2-(4-Chlorophenoxy)-4-(dimethylamino)-3-pyridinecarbonitrile
2-methoxy-N-[2-(methylthio)phenyl]benzamide
C15H15NO2S (273.08234500000003)
N-[4-(2-pyridinyl)-2-thiazolyl]cyclopentanecarboxamide
Evaclin; Evadol; Isodianidylethanolamine; LC 2
C16H19NO3 (273.13648639999997)
1-[2-(3-Methoxyphenyl)ethyl]-6-oxo-1,6-dihydropyridine-3-carboxylic acid
2-[4-(aminomethyl)phenyl]-3,5,7,8-tetrahydro-4H-thiino[4,3-d]pyrimidin-4-one
5-(1,3-Benzodioxol-5-yl)-N,N-diethyl-2,4-pentadienamide
C16H19NO3 (273.13648639999997)
N-{[(2s,3s)-3-(Ethoxycarbonyl)oxiran-2-Yl]carbonyl}-L-Isoleucine
3-Amino-3-benzyl-9-carboxamide[4.3.0]bicyclo-1,6-diazanonan-2-one
C15H19N3O2 (273.14771939999997)
5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid
Prodolic acid
C16H19NO3 (273.13648639999997)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
5950-12-9
C16H19NO3 (273.13648639999997)
Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].
4-(4-Cyclohexylanilino)-4-oxobut-2-enoic acid
C16H19NO3 (273.13648639999997)
4-Methoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(2S)-2-azaniumyl-3-[4-(4-hydroxyphenoxy)phenyl]propanoate
N(2)-(3-carboxylatopropionyl)-L-arginine(1-)
An N-acyl-L-alpha-amino acid anion that is the conjugate base of N(2)-succinyl-L-arginine, arising from deprotonation of the carboxy groups and protonation of the amino group; major species at pH 7.3.
Methylglutaconyl hydroxy ornithine
C11H17N2O6- (273.10865620000004)
L-alanyl-(2S,3E)-amino-4-methoxy-but-3-enoyl-L-alanine
(2S)-2-[[(E,2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methoxybut-3-enoyl]amino]propanoic acid
Ketalar
C13H17Cl2NO (273.06871320000005)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2-[[1-(4-Ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile
N-(4-methoxyphenyl)-2-(methylthio)benzamide
C15H15NO2S (273.08234500000003)
1-(4-Methoxyphenyl)-3-(6-methyl-2-pyridinyl)thiourea
1-(3-Pyridin-4-yl-4-oxa-1,2-diaza-spiro[4.6]undec-2-en-1-yl)-ethanone
C15H19N3O2 (273.14771939999997)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,5-dimethyl-4-pyrazolecarboxamide
N-[[(cyclohexylamino)-sulfanylidenemethyl]amino]carbamic acid tert-butyl ester
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dimethyl-3-furamide
4-[(2-Methoxy-1-naphthalenyl)methyl]thiomorpholine
2-methyl-N-[(E)-(2-nitrophenyl)methylideneamino]pyrazole-3-carboxamide
N-(5-fluoro-2-methylphenyl)-1,3-benzodioxole-5-carboxamide
O-glutaconyl-L-carnitine
An O-acyl-L-carnitine where the acyl group specified is glutaconyl.
3-[1-(pentylamino)ethylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione
C16H19NO3 (273.13648639999997)
4-[[2-Furanyl(oxo)methyl]amino]benzoic acid propan-2-yl ester
N-[4-cyano-5-methyl-2-oxo-3-(trifluoromethyl)-1H-pyrrol-3-yl]cyclopropanecarboxamide
3-[1-(Carboxymethyl)-5-phenyl-2-pyrrolyl]propanoic acid
1-methyl-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea
1-[2-[2-(2,3-dihydro-1H-inden-5-yloxy)ethoxy]ethyl]-1,2,4-triazole
C15H19N3O2 (273.14771939999997)
4-(2,4-dimethoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one
methyl (4Z)-4-(furan-2-ylmethylidene)-2-methyl-5-oxo-1-prop-2-enylpyrrole-3-carboxylate
3-(1,3-Benzoxazol-2-ylsulanyl)-5,5-dimethylcyclohex-2-en-1-one
C15H15NO2S (273.08234500000003)
2-(4-chlorophenyl)-N-[(E)-pyridin-4-ylmethylideneamino]acetamide
N-methyl-3-[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
C15H19N3O2 (273.14771939999997)
(4-Tert-butylphenyl) 3,5-dimethyl-1,2-oxazole-4-carboxylate
C16H19NO3 (273.13648639999997)
O-glutaconylcarnitine
An O-acylcarnitine in which the acyl group specified is glutaconyl.
(E)-5-acetyl-3-(1-(2,2-dimethylhydrazineyl)propylidene)indolin-2-one
C15H19N3O2 (273.14771939999997)
(2E)-7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoate
(E,6R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhept-2-enoate
[(2S)-1-(1H-indol-3-yl)-4-methyl-3-oxopentan-2-yl] acetate
C16H19NO3 (273.13648639999997)
2-(N-Benzyloxycarbonyl-N-methylamino)ethylphosphonic acid
(E)-3-(Ethoxycarbonylmethylene)-1-para-tolyl-2,5-pyrrolidinedione
oscr#7(1-)
A hydroxy fatty acid ascaroside anion resulting from the deprotonation of the carboxy group of oscr#7. The conjugate base of oscr#7 and the major species at pH 7.3.
SIB-1553A
SIB-1553A is an orally bioavailable nicotinic acetylcholine receptors (nAChRs) agonist, with selectivity for β4 subunit-containing nAChRs. SIB-1553A is also a selective neuronal nAChR ligand. SIB-1553A is a cognitive enhancer, and has therapeutic potential for the symptomatic treatment of Alzheimer’s disease and other cognitive disorders[1][2].
1-[(3r)-2,3-dihydroxy-5-(3-methylbut-2-en-1-yl)indol-3-yl]propan-2-one
C16H19NO3 (273.13648639999997)
5-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one
C16H19NO3 (273.13648639999997)
9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylacetate
C16H19NO3 (273.13648639999997)
(1r,10r,12s)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
9-methoxy-2,2-dimethylpyrano[3,2-c]quinoline-5,7-diol
(2r)-2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one
C16H19NO3 (273.13648639999997)
4-methoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one
C16H19NO3 (273.13648639999997)
(10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol
C16H19NO3 (273.13648639999997)
5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol
C16H19NO3 (273.13648639999997)
(1s,15r,16r)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol
C16H19NO3 (273.13648639999997)
(2z,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
(1s,15r,16s)-5-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-4,15-diol
C16H19NO3 (273.13648639999997)
3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
2-hydroxy-7-(hydroxymethyl)-2-isopropylfuro[3,2-h]isoquinolin-3-one
2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione
C16H19NO3 (273.13648639999997)
(2e,4e,6e)-1-(piperidin-1-yl)-7-(thiophen-2-yl)hepta-2,4,6-trien-1-one
4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(1s,14r)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol
C16H19NO3 (273.13648639999997)
16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one
C16H19NO3 (273.13648639999997)
3-[(2e)-but-2-en-1-yl]-4-ethoxy-8-hydroxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(1r,10s,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(1s,15r,16s)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol
C16H19NO3 (273.13648639999997)
(1r,9s,10r,13s,14r,16s)-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione
C16H19NO3 (273.13648639999997)
2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one
C16H19NO3 (273.13648639999997)
4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol
C16H19NO3 (273.13648639999997)
5,7-dioxa-11-azapentacyclo[9.6.1.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]octadeca-2,4(8),9,14-tetraene-16,17-diol
3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(1s,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol
C16H19NO3 (273.13648639999997)
2-hydroxy-4-(4-hydroxy-3-methylphenoxy)-6-methylbenzenecarboximidic acid
5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol
C16H19NO3 (273.13648639999997)
(6r,7s)-6,10-dihydroxy-7-methoxy-3-methyl-6h,7h,8h-cyclohexa[g]isoquinolin-9-one
(1r,2s)-2-hydroxy-1-methoxy-1,2-dimethyl-9h-carbazole-3,4-dione
(1r,13r,15s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol
C16H19NO3 (273.13648639999997)
14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione
C16H19NO3 (273.13648639999997)
(1s,16s,17s,18s)-5,7-dioxa-11-azapentacyclo[9.6.1.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]octadeca-2,4(8),9,14-tetraene-16,17-diol
6,10-dihydroxy-7-methoxy-3-methyl-6h,7h,8h-cyclohexa[g]isoquinolin-9-one
(1r,10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol
C16H19NO3 (273.13648639999997)
1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate
C16H19NO3 (273.13648639999997)
4-methoxy-1-methyl-8-[(3-methylbut-2-en-1-yl)oxy]quinolin-2-one
C16H19NO3 (273.13648639999997)
4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butanoic acid
4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol
C16H19NO3 (273.13648639999997)
3,4-dihydroxy-n-[2-(4-hydroxyphenyl)ethyl]benzenecarboximidic acid
5-(2h-1,3-benzodioxol-5-yl)-n-(sec-butyl)penta-2,4-dienamide
C16H19NO3 (273.13648639999997)
4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one
C16H19NO3 (273.13648639999997)
(4z,5e)-4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one
C16H19NO3 (273.13648639999997)
(3s,6s)-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol
(2e,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
(1s,10r,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(1s,13s)-9-hydroxy-5-methyl-4,12-dioxa-14-azatetracyclo[11.3.1.0²,¹¹.0³,⁸]heptadeca-2,5,8,10-tetraen-7-one
(2e)-3-(2h-1,3-benzodioxol-5-yl)-1-(4-methylpiperidin-1-yl)prop-2-en-1-one
C16H19NO3 (273.13648639999997)
(1s,2s,13r,15r)-2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione
C16H19NO3 (273.13648639999997)
4,8-dimethoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol
C16H19NO3 (273.13648639999997)
2-hydroxy-1-methoxy-1,2-dimethyl-9h-carbazole-3,4-dione
2-hydroxy-3-[(2-hydroxyphenyl)amino]-6-imino-5-oxocyclohexa-1,3-diene-1-carboximidic acid
3-(3-hydroxy-3-methylbut-1-en-1-yl)-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(2r)-1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate
C16H19NO3 (273.13648639999997)
(1s,12s,14s)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol
C16H19NO3 (273.13648639999997)
5-{[2-(4-hydroxyphenyl)ethyl](methyl)amino}-2-methoxyphenol
C16H19NO3 (273.13648639999997)
(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienamide
C16H19NO3 (273.13648639999997)
(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one
C16H19NO3 (273.13648639999997)
3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(2e)-3-(2h-1,3-benzodioxol-5-yl)-n-cyclohexylprop-2-enimidic acid
C16H19NO3 (273.13648639999997)